Modulation of insulin-regulated aminopeptidase (IRAP)/Angiotensin IV (AT4) receptor activity
Details for Australian Patent Application No. 2002317634 (hide)
International Classifications
Event Publications
9 January 2003 Complete Application Filed
Priority application(s): 60/330,170 17.10.01 US; PR 6772 02.08.01 AU
29 May 2003 Application Open to Public Inspection
Published as AU-B-2002317634
1 May 2008 Application Accepted
Published as AU-B-2002317634
28 August 2008 Standard Patent Sealed
25 September 2008 Corrigenda
Applications Accepted - Name Index Under the name Howard Florey Institute of Experimental Physiology and Medicine, Application No. 2002317634, under INID(72), correct the co-inventor name to McDowall, Sharon, G
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002317635-METHODS OF SCREENING BASED ON THE EGF RECEPTOR CRYSTAL STRUCTURE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser